Teracyte Analytics

Company Overview

Snapshot

Founded in March 2020 by Yoav Nissan-cohen and Gal Lenz, Teracyte Analytics is a Health Tech & Life Sciences company with 11–50 employees. The company has raised $1.5 million across one funding round from one investor. In January 2022, Teracyte Analytics secured a grant from the Israel Innovation Authority.

Business overview

Teracyte Analytics develops a platform for high-throughput temporal analysis of live single-cells, leveraging proprietary array chips, an imaging system, and advanced analytical tools. This platform enables the capture and retention of suspension cells in dedicated arrays, facilitating real-time monitoring of cell function through high-sensitivity fluorescent imaging and high-resolution brightfield imaging. Utilizing AI models, Teracyte Analytics can differentiate cell types, count cells, and identify cell-cell interactions, offering solutions for discovery, development, and manufacturing in cell therapies, biological drugs, and small molecule drugs. The company operates within the Health Tech & Life Sciences sector, specifically targeting the Pharma & Medical Biotechnology and Drugs Discovery & Development industries.

Company Intelligence Q&A

What is Teracyte Analytics' core technology?

Teracyte Analytics has developed a platform for high-throughput temporal analysis of live single-cells. This platform integrates proprietary array chips, an imaging system, and analytical tools to capture and monitor suspension cells in real-time.

When was Teracyte Analytics founded and by whom?

Teracyte Analytics was founded in March 2020 by co-founders Yoav Nissan-cohen and Gal Lenz.

What is the primary application of Teracyte Analytics' solution?

Teracyte Analytics' solution is designed for use in the discovery, development, and manufacturing of cell therapies, biological drugs, and small molecule drugs, providing insights into cell function and interactions.

What is the total capital raised by Teracyte Analytics?

Teracyte Analytics has raised a total of $1.5 million across one funding round.

What kind of funding did Teracyte Analytics receive in January 2022?

In January 2022, Teracyte Analytics secured a grant from the Israel Innovation Authority.